POPULATION PK AND EXPOSURE-RESPONSE ANALYSES OF APREMILAST IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kassir, N. [1 ]
Savant, I. [2 ]
Mouksassi, M. S. [1 ]
Marier, J. F. [1 ]
Zhu, W. [2 ]
Lau, H. [2 ]
机构：
[1] Pharsight Corp, Montreal, PQ, Canada
[2] Celgene Corp, Summit, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [21] Oral Apremilast is Effective in the Treatment of Subjects with Active Psoriatic Arthritis with and without Concomitant Methotrexate Therapy
    Schett, Georg
    Hu, Angela
    Stevens, Randall
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1709 - 1710
  • [22] POPULATION-PK (POPPK) AND EXPOSURE-RESPONSE (ER) ANALYSES FOR BELZUTIFAN TO INFORM DOSING CONSIDERATIONS AND LABELING.
    Marathe, D.
    Jauslin, P.
    Kleijn, H.
    Silva, C. De Miranda
    Abraham, A.
    Kauh, E.
    Liu, Y.
    Perini, R.
    De Alwis, D.
    Jain, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S35 - S35
  • [23] POPULATION PHARMACOKINETICS (PK) OF LEBRIKIZUMAB AND EXPOSURE-RESPONSE (ER) ANALYSES OF PHASE III STUDIES IN SEVERE ASTHMA PATIENTS
    Zhu, R.
    Dirks, N. L.
    Vadhavkar, S.
    Jin, J. Y.
    Holweg, C.
    Olsson, J.
    Matthews, J.
    Putnam, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S95 - S95
  • [24] Population pharmacokinetics and exposure-response analyses of varenicline in adolescent smokers
    Fediuk, Daryl J.
    Sweeney, Kevin
    Sahasrabudhe, Vaishali
    McRae, Thomas
    Byon, Wonkyung
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (07): : 769 - 781
  • [25] Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses
    Tamai, Toshiyuki
    Hayato, Seiichi
    Hojo, Seiichiro
    Suzuki, Takuya
    Okusaka, Takuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (09): : 1138 - 1147
  • [26] Oral Apremilast Is Effective with and without Concomitant Methotrexate Therapy in the Treatment of Subjects with Active Psoriatic Arthritis.
    Schett, Georg A.
    Hu, Angela
    Stevens, Randall
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S306 - S307
  • [27] Population Pharmacokinetics and Exposure-Response Modeling Analyses of Ustekinumab in Adults With Moderately to Severely Active Ulcerative Colitis
    Xu, Yan
    Hu, Chuanpu
    Chen, Yang
    Miao, Xin
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Sharma, Amarnath
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (07): : 889 - 902
  • [28] Population Pharmacokinetics and Exposure-Response Analyses of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Gasink, Christopher
    Kowalski, Ken
    Sandborn, William J.
    Feagan, Brian
    CLINICAL THERAPEUTICS, 2022, 44 (10) : 1336 - 1355
  • [29] Population Pharmacokinetic and Exposure-Response Analyses for Efficacy and Safety of Risankizumab in Patients With Active Crohn's Disease
    Suleiman, Ahmed Abbas
    Goebel, Aline
    Bhatnagar, Sumit
    D'Cunha, Ronilda
    Liu, Wei
    Pang, Yinuo
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (04) : 839 - 850
  • [30] Population Pharmacokinetics and Exposure-Response Modeling Analyses of Golimumab in Children With Moderately to Severely Active Ulcerative Colitis
    Xu, Yan
    Adedokun, Omoniyi J.
    Chan, Daphne
    Hu, Chuanpu
    Xu, Zhenhua
    Strauss, Richard S.
    Hyams, Jeffrey S.
    Turner, Dan
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (04): : 590 - 604
12345